InterCure Ltd. INCR
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 41.08% | 36.63% | 7.80% | 4.75% | -20.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.08% | 36.63% | 7.80% | 4.75% | -20.77% |
| Cost of Revenue | 41.08% | 36.64% | 11.34% | 8.19% | 4.88% |
| Gross Profit | 39.58% | 35.10% | 0.66% | -2.19% | -98.89% |
| SG&A Expenses | -2.51% | -5.58% | -7.43% | -10.05% | 41.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -38.40% | -40.34% | 52.10% | 53.46% | 1,088.15% |
| Total Operating Expenses | 14.86% | 11.24% | 12.19% | 9.02% | 35.75% |
| Operating Income | 15.34% | 18.00% | -41.37% | -43.04% | -660.99% |
| Income Before Tax | 46.41% | 48.10% | -262.45% | -257.82% | -44.02% |
| Income Tax Expenses | 51.41% | 52.94% | -134.17% | -133.20% | -523.79% |
| Earnings from Continuing Operations | 45.31% | 47.03% | -31,550.00% | -31,225.00% | -11.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -69.11% | -70.07% | -92.17% | -92.42% | 1,145.60% |
| Net Income | 44.09% | 45.85% | -223.95% | -220.44% | -6.26% |
| EBIT | 15.34% | 18.00% | -41.37% | -43.04% | -660.99% |
| EBITDA | 16.50% | 19.13% | -10.77% | -13.30% | -962.52% |
| EPS Basic | 51.49% | 53.02% | -204.48% | -200.98% | -8.28% |
| Normalized Basic EPS | 23.69% | 26.09% | -150.00% | -148.59% | -373.52% |
| EPS Diluted | 51.55% | 53.08% | -204.48% | -200.98% | -8.39% |
| Normalized Diluted EPS | 23.69% | 26.09% | -150.00% | -148.59% | -373.52% |
| Average Basic Shares Outstanding | 15.27% | 15.27% | 18.91% | 18.91% | -1.87% |
| Average Diluted Shares Outstanding | 15.27% | 15.27% | 18.91% | 18.91% | -1.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |